Patrick Jimonet

Riluzole Series. Synthesis and in Vivo “Antiglutamate” Activity of 6-Substituted-2-benzothiazolamines and 3-Substituted-2-imino-benzothiazolines

Patrick Jimonet, F. AUDIAU, Michel Barreau et al. · Journal of Medicinal Chemistry · 1999 · 230 citations

Bioorganic Chemistry, Organic Chemistry, Pharmacotherapy +18

RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.

Thierry Canton, Böhme Ga, Alain Boireau et al. · PubMed · 2001 · 68 citations

Neurotransmitter, Brain Penetration, Rpr 119990 +17

RPR 119990, a Novel α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Antagonist: Synthesis, Pharmacological Properties, and Activity in an Animal Model of Amyotrophic Lateral Sclerosis

Thierry Canton, Georg Andrees Böhme, Alain Boireau et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 46 citations

Strategies for designing GPCR-focused libraries and screening sets.

Patrick Jimonet, Robert De Jager · PubMed · 2004 · 41 citations

Drug Target, Medicinal Chemistry, Drug Design +20

9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic Acid (RPR117824): Selective Anticonvulsive and Neuroprotective AMPA Antagonist

Serge Mignani, Georg Andrees Böhme, Guillaume Birraux et al. · Bioorganic & Medicinal Chemistry · 2002 · 35 citations